Clinical Trials on Síndrome de Baetz-Greenwalt
Total 0 results
Nothing found
Sponsors and Collaborators
- Ionis Pharmaceuticals
- Wushan County People's Hospital
- Jeffrey W. Clark, MD
- Honda R and D Americas, Inc.
- Marilia Medicine School
- MingSight Pharmaceuticals Pty Limited
- Montreal Neurological Institute and Hospital
- Rex Bionics Plc
- The Third Hospital of Changsha
- Northern California Melanoma Center
- Kawin Technology Share-holding Co., Ltd.
- Health Parametrics Inc.
- New York State Health Foundation
- Medtronic Atrial Fibrillation Solutions
- CTC Bio, Inc.
- Zahra Rabbani Khah
- Jeffrey Rudolph
- Mitchell Scheiman
- European Network For Smoking and Tobacco Prevention
- John Granton
- View Full List
Medical Conditions
- Periferal Arterial Occlusive Disease, PAOD
- Metastatic Spine Lesions
- Liver Hemangioma
- Brain MRI
- Advanced Esophageal Cancers
- HDT-AHCT
- Primary Generalized Dystonia
- Pregnancy-Related Condition, Unspecified
- Waldenstrom's Macroglobulinemia Recurrent
- H.Pylori Infection
- Ascaris Suum
- Locally Advanced NSCLC
- Fasting, Diet, Chemotherapy, Toxicity
- Renal Cancer Metastatic
- ACTH-Secreting Pituitary Adenoma
- Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
- Pancreatic Neoplasms
- LSIL
- Hyperthyroidism, Autoimmune
- Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.
- View Full List
Drug Interventions
- Levobupivacaine, clonidine
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Bendamustine
- Rifaximin
- Hydroxychloroquine
- Ombrabulin (AVE8062)
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- Levcromakalim
- Fludarabine
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- CKD-519
- Nimotuzumab
- Postoperative analgesia management
- Toripalimab plus Anlotinib
- Pentostatin
- 200 µg doxorubicin-containing MNA
- ESK981
- AZD7798
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- View Full List
CROs by country
- Contract Research Organizations in Brazil
- Contract Research Organizations in Chile
- Contract Research Organizations in Congo
- Contract Research Organizations in Iran
- Contract Research Organizations in Jordan
- Contract Research Organizations in Liberia
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Oman
- Contract Research Organizations in Romania
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Serbia
- Contract Research Organizations in Uruguay
- Contract Research Organizations in Zimbabwe
- CRO list by country